The Generic Medicines Australia conference was a big hit last year, and I’ll be speaking at the 2008 conference.
First up, I’ll participate in a panel discussion entitled “Patents vs. patients: examining the effect of patent legislation on the pharmaceutical industry”.
In a subsequent session, I will take the audience through what has been happening in India (and other countries) over the patentability of Glivec (Gleevec) crystalline forms and what it might mean for the future.
For those of you interested in the Australian pharmaceutical scene – I hope to see you there.